ReviewFrontiers in immunology2022
CARMA3: A potential therapeutic target in non-cancer diseases.
Zhen Gui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Zhen Gui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.